Medicines Marketed by Eskag Pharma pvt ltd

About Eskag Pharma Pvt Ltd

Eskag Pharma Pvt Ltd is a renowned pharmaceutical manufacturer based in Kolkata, West Bengal, India. This company was established in 1977 and has been a cornerstone of the Eskag Group of Companies for over 47 years. Eskag Pharma operates in the pharmaceutical and medicine manufacturing sector, embodying a legacy of excellence and innovation. Along with basic chemical manufacturing, it is deeply involved in the development, production, and marketing of a wide range of pharmaceutical products.

Eskag Pharma has a significant global presence and its products are trusted by healthcare professionals in over 20 countries worldwide. Its manufacturing facilities are certified by WHO-GMP and ISO-9001:2008 thus ensuring the delivery of premium products in line with international standards. Eskag Pharma's foundation is deeply rooted in research and development, with significant investments driving innovation and addressing critical health challenges.

Eskag Pharma Pvt Ltd Products

Eskag Pharma Pvt Ltd manufactures a diverse and robust range of pharmaceutical products, including speciality medicines, generic and OTC products, and active pharmaceutical ingredients (APIs). The company's speciality medicines address various therapeutic areas such as anti-ulcerants, digestive enzymes, antacids, formulations of probiotics and prebiotics, antidiarrhoeals, Oral Rehydration Solutions (ORS), and oral contraceptive pills. Some of their most popular products include Evaday, Folcovit, Biogut, the Magnate Family of Brands, Suvida & Suvida 72, Relux, and Sufrate.

Eskag Pharma Pvt Ltd stands out due to its stringent commitment to quality and innovation. The company's manufacturing processes adhere to international standards, including WHO-GMP and ISO-9001:2008 certifications, ensuring the delivery of premium products. Additionally, the company has a strong foundation in research and development, with significant investments aimed at addressing critical health challenges and leading the front line of pharmaceutical innovation.